SkyQuest Technology Group recently introduced Liquid Biopsy Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Liquid Biopsy Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Liquid Biopsy Market size was valued at USD 10.32 Billion in 2023 and is poised to grow from USD 11.48 Billion in 2024 to USD 26.85 Billion by 2032, growing at a CAGR of 11.21% during the forecast period (2025-2032).
The Liquid Biopsy Market is witnessing notable growth due to increasing demand across various industries and advancements in technology. Factors such as rising consumer awareness, evolving regulations, and the push for sustainable and innovative solutions are driving market expansion. Additionally, the adoption of Liquid Biopsy Market is fueled by its versatile applications and growing focus on efficiency, quality, and performance.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/liquid-biopsy-market
The 2025 global Liquid Biopsy Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Liquid Biopsy Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Liquid Biopsy Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Product & Services
Assay Kits, Instruments, and Services
Circulating Biomarker
Circulating Tumor Cells, Circulating Tumor DNA, Circulating Nucleic Acids Exosome/Microvesicle, Cell-free DNA, Extracellular Vesicles, and Others
Clinical Application
Early Cancer Screening, Therapy Selection, Treatment Monitoring, and Recurrence Monitoring
Technology
Multi-Gene Parallel Analysis using NGS, and Single-Gene Analysis using PCR
Application
Cancer Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others), Non-Cancer Application (Non-Invasive Prenatal Testing, Organ Transplantation, Infectious Disease Testing), and Reproductive Health
Sample Type
Blood Samples, Urine Sample, Saliva Sample, and Others
End User
Hospitals & Clinics, Diagnostic Centers, Reference Laboratories, Academic & Research Centers, and Others
Liquid Biopsy Market – Regional Analysis:
– Liquid Biopsy North America Market includes (Canada, Mexico, USA)
– Liquid Biopsy Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Liquid Biopsy Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Liquid Biopsy South America Market includes (Brazil, Argentina)
– Liquid Biopsy Oceania Market (Australia & New Zealand)
Top Market Players in Liquid Biopsy Market are:
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc. (US)
Guardant Health, Inc. (US)
Biocept, Inc. (US)
Sysmex Corporation (Japan)
Menarini Silicon Biosystems (Italy)
Natera, Inc. (US)
Biocartis Group NV (Belgium)
Personal Genome Diagnostics Inc. (US)
Bio-Rad Laboratories, Inc. (US)
OncoCyte Corporation (US)
Adaptive Biotechnologies Corporation (US)
Angle plc (United Kingdom)
Epic Sciences, Inc. (US)
NEOGENOMICS LABORATORIES (US)
CellMax Life (US)
MENARINI-SILICON BIOSYSTEMS (Italy)
LUNGLIFE AI, INC. (US)
VORTEX BIOSCIENCES (US)
Take Action Now: Secure Your Liquid Biopsy Market Today – https://www.skyquestt.com/buy-now/liquid-biopsy-market
FAQ
– What challenges and constraints are affecting the market?
– What geographical variables are influencing the Liquid Biopsy market?
– How does the Value Chain concept offer insights into market dynamics?
– Which country dominates the market?
– Which is the leading formulation type for Liquid Biopsy Market?
Forward-Looking Insights
The Liquid Biopsy Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
